Safety & Efficacy of Durvalumab+Neoadjuvant Chemotherapy for High-risk Urothelial Carcinoma of the Upper Urinary Tract

Abroad (travel likely)RecruitingPHASE2

Conditions

Urothelial Carcinoma · Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Hôpital Bichat-Claude Bernard, Paris, Paris Cx 20, France
Contact: Study coordinator (Evanguelos XYLINAS) · evanguelosxylinas@aphp.fr
Institut Paoli Calmette, Marseille, France
Contact: Study coordinator (Gwénaëlle Gravis) · gravisg@ipc.unicancer.fr
Hôpital Saint Louis, Paris, France
Contact: Study coordinator (Alexandra Masson-Lecomte) · alexandra.massonlecomte@aphp.fr
Hôpital Pitié Salpétrière, Paris, France
Contact: Study coordinator (Morgan ROUPRET, PUPH) · mroupret@gmail.com · 01 42 17 72 97
Hôpital Européen Georges Pompidou, Paris, France
Contact: Study coordinator (François Audenet) · francois.audenet@gmail.com
Centre hospitalier Lyon Sud, Pierre-Bénite, France
Contact: Study coordinator (Sophie TARTAS) · Sophie.tartas@chu-lyon.fr
Centre Eugène Marquis, Rennes, France
Contact: Study coordinator (Brigitte LAGUERRE) · b.laguerre@rennes.unicancer.fr · 0299253182
Hôpital Foch, Suresnes, France
Contact: Study coordinator (Yann Neuzillet) · y.neuzillet@hopital-foch.org
Iuct Oncopole, Toulouse, France
Contact: Study coordinator (Damien POUESSEL) · pouessel.damien@iuct-oncopole.fr

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

Breast Cancer · Gastric Cancer · Esophageal Cancer

Abroad (travel likely)RecruitingPHASE2

Prescott, United States · Littleton, United States

Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer

Small Cell Neuroendocrine Carcinoma of Bladder · Bladder Cancer · Urothelial Carcinoma Bladder

Abroad (travel likely)RecruitingPHASE2

Washington D.C., United States · Baltimore, United States

Adjuvant Sacituzumab Govitecan and Nivolumab in Muscle-Invasive Urothelial Carcinoma at High-Risk Recurrence

Urothelial Carcinoma · Muscle-invasive Bladder Cancer

Abroad (travel likely)RecruitingPHASE2

Orange, United States

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

Head and Neck Squamous Cell Carcinoma (HNSCC) · Non-small Cell Lung Cancer (NSCLC) · Esophageal Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Los Angeles, United States · Grand Rapids, United States